InnoMx

InnoMx is a consultancy specializing in pharmacometrics, quantitative clinical pharmacology, model-informed drug development, and regulatory strategy. The founder has contributed to over a dozen regulatory filings and drug approvals since 2005. The company partners with Pumas-AI to provide advanced modeling tools for clients in the pharmaceutical industry. Areas of expertise include exposure-response analysis for time-to-event endpoints with time-varying exposure, monoclonal antibody pharmacokinetics, clinical trial simulations, and interactive data analysis/visualization using R Shiny apps. Services are tailored to support efficient and informed decision-making throughout the drug development process [1].